01-02-2024 | Ocrelizumab | Case report
Ocrelizumab/rituximab
Febrile neutropenia, neutropenia and infusion-related reaction in the form of flares of cutaneous eruptions
Published in: Reactions Weekly | Issue 1/2024
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event